Schrödinger, Inc. Profile Avatar - Palmy Investing

Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The …
Medical - Healthcare Information Services
US, New York [HQ]

News

Theses · Events · Sentiments
Sentiments
24-10-23 37.60%

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, during a poster session …

End of SDGR's Analysis
CIK: 1490978 CUSIP: 80810D103 ISIN: US80810D1037 LEI: - UEI: -
Secondary Listings
SDGR has no secondary listings inside our databases.